Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADGRA1 antisense RNA 1 (ADGRA1-AS1) is a long non-coding RNA gene that is located on chromosome 10 and does not encode a protein. It is classified as an antisense RNA because it is transcribed from the strand opposite to the protein-coding ADGRA1 gene (adhesion G protein-coupled receptor A1). ADGRA1-AS1, also called GPR123-AS1, consists of multiple splice variants and may play regulatory roles at the RNA level, but it is not characterized as a therapeutic target, receptor, enzyme, or transporter. No disease associations, drug interactions, or biomarker uses have been reported in major gene databases[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADGRA1 antisense RNA 1 (ADGRA1-AS1).